The series advances the Cambridge NeuroWorks mission to accelerate scalable treatments for neurological conditions such as Parkinson’s disease and stroke paralysis, spotlighting breakthroughs in neurotechnology – from neural-interfacing bioelectronics to wearable digital monitoring – and how they are reshaping healthcare.
Sessions will feature internationally recognised researchers and innovators, with opportunities for live Q&A. The talks will be chaired by Professor George Malliaras, Prince Philip Professor of Technology in the Department of Engineering at the University of Cambridge, whose post-presentation discussions promise additional insight and debate.
Anyone interested in how neurotechnology is shaping the future of healthcare, from researchers and clinicians to industry and innovation professionals.
13 Jan 2026 – Zhenan Bao, K.K. Lee Professor of Chemical Engineering at Stanford University Department of Chemical Engineering. Talk: NeuroString: a soft multi-modal 1D sensing fiber for the brain and guts.
20 Jan 2026 – Professor Steve Xu, Medical Director of the Querrey Simpson Institute for Regenerative Engineering at Northwestern University. Talk: Digital Health Solutions for Neurological Conditions: Applications in Parkinson’s Disease and Beyond.
27 Jan 2026 – Wei Gao, Professor at The California Institute of Technology (Caltech). Talk: Body-interfaced biosensors.
Cambridge Neuroscience is proud to be a partner in the ARIA Activation Partner Programme through Cambridge NeuroWorks. Together with eight other leading Cambridge-based institutions, we’re working to build a future where neurological disorders no longer limit human potential. Join our community.
Posted on 07/01/2026
